FIELD: pharmaceuticals.
SUBSTANCE: present invention discloses a pharmaceutical solid solution composition for the treatment of a severe pain condition consisting of ibuprofen, pharmaceutically acceptable triglycerides having a melting point in the range of 41 °C to 45 °C, one or more monoglyceride comprising glycerin monolinoleate, polyethylene glycol.
EFFECT: disclosed is the use of a pharmaceutical composition for the treatment of severe pain.
46 cl, 13 dwg, 22 ex, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID SOLUTION COMPOSITIONS AND USE IN CHRONIC INFLAMMATION | 2014 |
|
RU2675241C2 |
| SOLID SOLUTION COMPOSITIONS AND THEIR USE IN CHRONIC INFLAMMATION | 2014 |
|
RU2779839C2 |
| SOLID SOLUTION COMPOSITIONS AND USE IN CARDIOVASCULAR DISEASE | 2014 |
|
RU2674982C2 |
| COMPOSITIONS AND METHODS FOR TREATMENT OF CHRONIC INFLAMMATION AND INFLAMMATORY DISEASES | 2012 |
|
RU2635188C2 |
| COMPOSITIONS AND METHODS FOR TREATING SEVERE PAIN | 2014 |
|
RU2677346C2 |
| PEGYLATED LIPID NANOPARTICLE WITH A BIOACTIVE LIPOPHILIC COMPOUND | 2016 |
|
RU2737893C2 |
| COMPOSITIONS AND METHODS OF TREATING CHRONIC INFLAMMATION AND INFLAMMATORY DISEASES | 2014 |
|
RU2680801C2 |
| TOPICAL COMPOSITIONS AND METHODS OF TREATMENT OF TOPICAL DISORDERS | 2014 |
|
RU2670750C9 |
| PRO-MEDICATION COMPOSITION FOR STRUGGLE AGAINST HEPAPATITIS C VIRUS | 2006 |
|
RU2435592C2 |
| ORAL CELECOXIB COMPOSITION FOR TREATING PAIN | 2016 |
|
RU2708254C2 |
